Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quick-start drospirenone versus combined oral contraceptive started on menstrual days 7-9
TCTR20220819001Phase 3Completed
- Sponsor
- Thai Red Cross Society
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of drospirenone, ethinyl estradiol, gestodene in contraception, sponsored by Thai Red Cross Society. Started Aug 2022; status: completed.
02
Drugs
drospirenoneethinyl estradiolgestodene
03
Conditions
contraception
Beyond the preview
Go deeper on TCTR20220819001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220819001.